The pharmaceutical giant Merck announced Monday it is acquiring rival Schering-Plough in a deal valued at $41 billion. Merck will pay a hefty premium for Schering in the cash and stock deal, which has already been approved by both boards.
5 x 8: Is the air going out of the NSA story?
America moves on after the spying scandal, the great gopher feet caper and other tales from the mean streets of Minnesota, return of the website, the grace of Steve Gleason, and the girl who makes your 12 year old look like a lazy punk.
7:37 a.m. more